Mammographic density and risk of breast cancer by mode of detection and tumor size: A case-control study

Breast Cancer Research

Volumn 18, Issue 1, 2016, Pages

  Krishnan, Kavitha ^a   Baglietto, Laura ^a,b,e,f   Apicella, Carmel ^a   Stone, Jennifer ^a,c   Southey, Melissa C ^g   English, Dallas R ^a,b   Giles, Graham G ^a,b,d   Hopper, John L ^a,h  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h Seoul National University   (South Korea)

Author keywords

Breast cancer; Detection mode; Mammographic density; Tumor size

Indexed keywords

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; BODY MASS; BREAST CANCER; BREAST DENSITY; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TUMOR GROWTH; TUMOR VOLUME; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; INCIDENCE; MIDDLE AGED; PATHOLOGY; PROCEDURES; RISK; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; BREAST DENSITY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; RISK; RISK FACTORS; TUMOR BURDEN;

EID: 84975296926     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-016-0722-4     Document Type: Article

References (29)

1. Wang AT, Vachon CM, Brandt KR, Ghosh K. Breast Density and Breast Cancer Risk: a Practical Review. Mayo Clin Proc. 2014;89:548-57.
2. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:1159-69.
3. Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014;106(5). doi: 10.1093/jnci/dju078.
4. Huo CW, Chew GL, Britt KL, Ingman WV, Henderson MA, Hopper JL, et al. Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat. 2014;144:479-502.
5. Price ER, Hargreaves J, Lipson JA, Sickles EA, Brenner RJ, Lindfors KK, et al. The California breast density information group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation. Radiology. 2013;269:887-92.
6. Brekelmans CT, van Gorp JM, Peeters PH, Collette HJ. Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups. Cancer. 1996;78:1220-8.
7. Baglietto L, Krishnan K, Stone J, Apicella C, Southey MC, English DR, et al. Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer. Am J Epidemiol. 2014;179:475-83.
8. Bulun SE, Chen D, Moy I, Brooks DC, Zhao H. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab. 2012;23:83-9.
9. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ. 2002;156:69-70.
10. Hopper JL. Odds per Adjusted Standard Deviation: Comparing strengths of associations for risk factors measured on different scales and across diseases and populations. Am J Epidemiol. 2015;182:863-7.
11. Nguyen TL, Aung YK, Evans CF, Yoon-Ho C, Jenkins MA, Sung J, et al. Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms. Breast Cancer Res. 2015;17:142.
12. Kim BK, Choi YH, Nguyen TL, Nam SJ, Lee JE, Hopper JL, et al. Mammographic density and risk of breast cancer in Korean women. Eur J Cancer Prev. 2015;24:422-9.
13. Pepe M, Longton G, Janes H. Estimation and comparison of receiver operating characteristic curves. Stata J. 2009;9:1.
14. Houssami N, Irwig L, Ciatto S. Radiological surveillance of interval breast cancers in screening programmes. Lancet Oncol. 2006;7:259-65.
15. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer. 2010.
16. Macinnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:2117-25.
17. Pollan M, Ascunce N, Ederra M, Murillo A, Erdozain N, Ales-Martinez JE, et al. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res. 2013;15:R9.
18. Ding J, Warren R, Girling A, Thompson D, Easton D. Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J. 2010;16:279-89.
19. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227-36.
20. Pettersson A, Tamimi RM. Breast fat and breast cancer. Breast Cancer Res Treat. 2012;135:321-3.
21. Stone J, Thompson DJ, Dos Santos SI, Scott C, Tamimi RM, Lindstrom S, et al. Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures. Cancer Res. 2015;75:2457-67.
22. Perry N, Broeders M, de Wolf C, Tornberg C, Holland R, von Karsa L. European guidelines for quality reassurance in breast cancer screening and diagnosis. Luxembourg: Office for Official Publications of the European Communities; 2006.
23. Boyd NF, Huszti E, Melnichouk O, Martin LJ, Hislop G, Chiarelli A, et al. Mammographic features associated with interval breast cancers in screening programs. Breast Cancer Res. 2014;16:417.
24. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92:1081-7.
25. Holm J, Humphreys K, Li J, Ploner A, Cheddad A, Eriksson M, et al. Risk factors and tumor characteristics of interval cancers by mammographic density. J Clin Oncol. 2015;33(9):1030-7. doi: 10.1200/jco.2014.58.9986.
26. Crane CE, Luke CG, Rogers JM, Playford PE, Roder DM. An analysis of factors associated with interval as opposed to screen-detected breast cancers, including hormone therapy and mammographic density. Breast (Edinburgh, Scotland). 2002;11:131-6.
27. Domingo L, Salas D, Zubizarreta R, Bare M, Sarriugarte G, Barata T, et al. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain. Breast Cancer Res. 2014;16:R3.
28. Nickson C, Arzhaeva Y, Aitken Z, Elgindy T, Buckley M, Li M, et al. AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes. Breast Cancer Res. 2013;15:R80.
29. Kavanagh AM, Byrnes GB, Nickson C, Cawson JN, Giles GG, Hopper JL, et al. Using mammographic density to improve breast cancer screening outcomes. Cancer Epidemiol Biomarkers Prev. 2008;17:2818-24.